Publications

Optimizing erlotinib plus sulindac dosing regimens in a preclinical model of FAP

Author(s): Ulusan Ahmetmursel,  Rajendran Praveen,  Dashwood Wan-Mohaiza,  Mohammed Altaf,  Sei Shizuko,  Brown Powel H.,  Vilar-Sanchez Eduardo,  Dashwood Roderick H.

Journal: Cancer Res

Date: 2019 Jul

Major Program(s) or Research Group(s): CADRG

PubMed ID:

PMC ID: not available

Abstract: